TRACI SCHUMACHER: Open Payments
NPI 1700517901 · ERIE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,162 in 125 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $516 · 2025 $2,162
Food & beverage: $2,050Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 49 | $719 |
| Otsuka America Pharmaceutical, Inc. | 20 | $320 |
| E.R. Squibb & Sons, L.L.C. | 18 | $222 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $203 |
| Vanda Pharmaceuticals Inc. | 6 | $177 |
| Axsome Therapeutics, Inc. | 3 | $160 |
| Alkermes, Inc. | 8 | $157 |
| Neurocrine BioSciences, Inc. | 4 | $96 |
| Lundbeck LLC | 3 | $49 |
| Janssen Pharmaceuticals, Inc | 1 | $22 |
Products named: UZEDY, COBENFY, CAPLYTA, REXULTI, FANAPT, AUSTEDO XR, Auvelity, ABILIFY ASIMTUFII.
Industry payments across PA — which companies pay providers there.
